Original paper
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
Abstract
Parkinson disease (PD) is a complex neurodegenerative disorder. Cognitive dysfunction and psychosis are leading contributors to nursing home placement.1 Psychosis onset is associated with cognitive decline, levodopa supplementation, and visual dysfunction.2 Treatment of PD psychosis (PDP) centers on levodopa dose adjustment, use of second-generation antipsychotics (SGAs), and cholinesterase inhibitors. SGAs function via serotonergic modulation...
Paper Details
Title
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
Published Date
Sep 27, 2018
Journal
Volume
91
Issue
17
Pages
797 - 799